In an animal study, the changes over time in plasma NOx levels and the expression of P-selectin on platelets after AF onset were explored, seeking to determine whether these biomarkers could be risk factors for silent cerebral infarction in AF patients. The gene discussed is SELP; the disease is cerebral infarction.